Article Versions Notes

Kimura K, Hayashi K, Sato M, Nakaya Y, Suzuki A, Takaku N, Hayashi H, Hayashi K, Miura T, Kobayashi Y. Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD). Diagnostics. 2025; 15(21):2723. https://doi.org/10.3390/diagnostics15212723

Kimura, Koichi, Koji Hayashi, Mamiko Sato, Yuka Nakaya, Asuka Suzuki, Naoko Takaku, Hiromi Hayashi, Kouji Hayashi, Toyoaki Miura, and Yasutaka Kobayashi. 2025. "Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD)" Diagnostics 15, no. 21: 2723. https://doi.org/10.3390/diagnostics15212723

Kimura, K., Hayashi, K., Sato, M., Nakaya, Y., Suzuki, A., Takaku, N., Hayashi, H., Hayashi, K., Miura, T., & Kobayashi, Y. (2025). Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD). Diagnostics, 15(21), 2723. https://doi.org/10.3390/diagnostics15212723